mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.0092 |
0.8 |
mRNA |
QS11 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.8 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.009 |
0.8 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0089 |
0.8 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0081 |
0.8 |
mRNA |
BIBR-1532 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
CID-5951923 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.0081 |
0.8 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
0.0095 |
0.8 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
-0.0099 |
0.8 |